Navigation Links
Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds
Date:5/27/2010

ere face-to-face encounters are not always feasible. The system is designed to be accessed from users' PCs and is fully integrated with the award-winning Zargis Cardioscan heart sounds analysis software and the Zargis StethAssist™ heart and lung sounds visualization software.

The U.S. and Europe are the dominant players in the worldwide telemedicine market, which is expected to reach $18 billion by 2015, according to a 2009 report by Global Industry Analysts, Inc., a global business strategy company.

"The rapidly-growing demand for streamlined telehealth tools is being driven by rising healthcare costs and the need to deliver care to homebound patients as well as underserved populations in remote and rural areas," stated Zargis CEO John Kallassy. "The ZargisTelemed system offers healthcare practitioners around the world with an efficient and highly cost-effective means to share and store stethoscope sounds in a way that's never before been possible."  

For more information about the ZargisTelemed system or to arrange a demonstration, call 609-488-4608.

About Zargis Medical Corp.

Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation.  Zargis is majority-owned by Speedus Corp. (Nasdaq: SPDE), and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), holds an equity position.

For additional information about Zargis or Speedus Corp., contact '/>"/>

SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Zargis Medical Strikes Gold at 2010 Edison Awards
2. Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia
3. Zargis Cardioscan Jointly Named as Finalist in 2010 Edison Best New Product Awards
4. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
5. Zargis Cardioscan Cleared for Sale in Canada
6. Zargis Cardioscan The Intelligent Stethoscope Now Available on Amazon.com
7. Zargis Cardioscan(TM) Featured on The Early Show on CBS
8. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
9. Ankota Launches Real-Time Family Communication Tool Tracking Health of Loved One
10. Thomson CompuMark Launches Worlds Most Comprehensive Trademark Search Offering for Pharmaceutical Brand Owners
11. Mylan Launches Temazepam Capsules USP, 7.5 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... RnRMarketResearch.com adds Corneal Ulcers ... to its store. This report p provides an ... The report "Corneal Ulcers - Pipeline Review, H2 2014" ... Corneal Ulcers. Corneal Ulcers are primarily result of ... infections & fungal infections. The symptoms of the ...
(Date:2/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ... in its neuroscience and oncology development programs have ... American Academy of Neurology annual meeting in ... 18-25. The accepted abstracts feature results from studies ... investigational treatments in AbbVie,s pipeline. Presentations will include ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... 23, 2012 Idenix Pharmaceuticals, Inc. (NASDAQ: ... and development of drugs for the treatment of human ... fourth quarter and year ended December 31, 2011 as ... (HCV) development pipeline. Operational HighlightsIDX184 ...
... Psychemedics Corporation (NASDAQ: PMD ) today announced ... December 31, 2011.  The Company also announced an increase in ... of record as of March 5, 2012 to be paid ... consecutive quarterly dividend. The Company,s revenue for the ...
Cached Medicine Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 7Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 8Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 2Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 3Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 4Psychemedics Corporation Announces a 20% Increase in Revenue and a 34% Increase in Profits for 2011 Year End 5
(Date:2/27/2015)... The V Foundation for Cancer Research, ... is excited to announce numerous promotions taking place this ... long-standing partnerships highlight The V Foundation’s significant work in ... for all to get involved. Awarding 100 percent ... The V Foundation has funded more than $130 million ...
(Date:2/27/2015)... 27, 2015 On February 24 2015, Harper’s ... Botox ,” that details the development of RT001, a ... its way through FDA trials. For those afraid of needles, ... very attractive. Of course, if the drug ultimately gets FDA ... physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, the ...
(Date:2/27/2015)... February 27, 2015 The Dawn Greene Hospice, ... Manning Walsh Home (MMW) on the Upper East Side, was ... of New York, His Eminence Timothy Michael Cardinal Dolan. , ... Board of Directors and a member of the ArchCare Board ... Sean William O’Brien, O.Carm, executive director of MMW, and Christina ...
(Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
(Date:2/27/2015)... Insight Accelerator Labs has partnered ... development of an in-line urine flow meter platform ... developed in direct response to current high cost ... error margins with potentially grave consequences. The company’s ... provide trending data analysis to signal ICU caregivers ...
Breaking Medicine News(10 mins):Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Is Topical Botox the Next Big Thing? 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... carotene, either individually or in combination, do not appear ... among women at high risk for heart disease, according ... Archives of Internal Medicine, one of the JAMA/Archives journals. ... oxygenmay contribute to the development of cardiovascular disease, according ...
... may produce beneficial changes in the brains and immune ... article posted online today that will appear in the ... of the JAMA/Archives journals. , In patients with multiple ... that protect nerve cells in the brain and spinal ...
... be associated with a decreasing peripheral field of vision ... remains low overall, according to a report in the ... JAMA/Archives journals. , Prevention of further visual field deterioration ... as background information in the article. Previous studies reported ...
... 2007, Paying out certain types of government aid in a ... and often fatal drug binges, according to a new study ... that links the monthly arrival of disability checks with a ... by researchers at the University of California, Santa Cruz and ...
... structural damage to DNA, players in two important pathways ... scientists at The University of Texas M. D. Anderson ... , This connection between a signaling pathway crucial to ... remodeling "opens an entirely new category of targets for ...
... 2007 New research from scientists at UT Southwestern ... underscores the importance of preventing recurring acid reflux while ... can turn potentially cancerous. , In research published in ... reflux disease, particularly those with a complication of acid ...
Cached Medicine News:Health News:Antioxidants show no clear benefit against cardiovascular events, death in high-risk women 2Health News:DNA vaccine against multiple sclerosis appears safe, potentially beneficial 2Health News:Fluctuating eye pressure associated with visual field deterioration in glaucoma patients 2Health News:Disability payments may spur drug abuse 2Health News:Chromatin remodeling complex connected to DNA damage control 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 2Health News:Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer 3
... The CMGS-1 Color Mini-Ganzfeld Stimulator is ... can be integrated with your existing LKC ... with other visual electrodiagnostic test systems. ... is the smallest commercial Ganzfeld to meet ...
... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...
... designed to facilitate an arthrodesis, either by ... interbody cages allowing radicular compression by restoring ... and of the foramina, which in turn ... for major lumbar instabilities.,CC cages are made ...
... SHELLGEL is a sterile nonpyrogenic, transparent ... SHELLGEL contains 12 mg/mL of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: